BRCA1 and breast carcinoma: Later on, a screen for FANCJ mutations in a Korean cohort with BRCA1/2 mutation-negative high-risk breast cancer identified the germline mutation c.1018C>T, giving rise to FANCJ L340F, as likely pathogenic [22].